Hernandez's Work Discussed in Context of "Opportunistic Behavior" in Drug Pricing

Pharmalot discusses Dr. Inma Hernandez's recent JAMA Internal Medicine letter on trends in drug prices and spending for TNF inhibitors in 2006-2016, and the opportunistic behavior to raise prices that the team's findings suggest.